Bridgeway Capital Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,003
| Closed | -$55.3K | – | 1280 |
|
|
2024
Q1 | $55.3K | Hold |
3,003
| – | – | ﹤0.01% | 1260 |
|
|
2023
Q4 | $47.7K | Hold |
3,003
| – | – | ﹤0.01% | 1317 |
|
|
2023
Q3 | $56.6K | Hold |
3,003
| – | – | ﹤0.01% | 1290 |
|
|
2023
Q2 | $67.9K | Buy |
+3,003
| New | +$67.9K | ﹤0.01% | 1306 |
|
|
2022
Q4 | – | Sell |
-7,000
| Closed | -$88K | – | 1384 |
|
|
2022
Q3 | $88K | Sell |
7,000
-5,000
| -42% | -$62.9K | ﹤0.01% | 1296 |
|
|
2022
Q2 | $117K | Sell |
12,000
-500
| -4% | -$4.88K | ﹤0.01% | 1198 |
|
|
2022
Q1 | $208K | Sell |
12,500
-4,860
| -28% | -$80.9K | ﹤0.01% | 1165 |
|
|
2021
Q4 | $441K | Buy |
17,360
+11,416
| +192% | +$290K | 0.01% | 1017 |
|
|
2021
Q3 | $266K | Hold |
5,944
| – | – | 0.01% | 1174 |
|
|
2021
Q2 | $240K | Sell |
5,944
-2,250
| -27% | -$90.8K | ﹤0.01% | 1239 |
|
|
2021
Q1 | $436K | Sell |
8,194
-5,999
| -42% | -$319K | 0.01% | 1128 |
|
|
2020
Q4 | $568K | Buy |
14,193
+5,343
| +60% | +$214K | 0.01% | 901 |
|
|
2020
Q3 | $504K | Hold |
8,850
| – | – | 0.01% | 881 |
|
|
2020
Q2 | $653K | Buy |
8,850
+2,500
| +39% | +$184K | 0.01% | 780 |
|
|
2020
Q1 | $315K | Buy |
6,350
+1,186
| +23% | +$58.8K | 0.01% | 917 |
|
|
2019
Q4 | $397K | Buy |
5,164
+445
| +9% | +$34.2K | 0.01% | 1062 |
|
|
2019
Q3 | $188K | Hold |
4,719
| – | – | ﹤0.01% | 1192 |
|
|
2019
Q2 | $159K | Hold |
4,719
| – | – | ﹤0.01% | 1211 |
|
|
2019
Q1 | $250K | Buy |
4,719
+1,500
| +47% | +$79.5K | ﹤0.01% | 1188 |
|
|
2018
Q4 | $151K | Sell |
3,219
-5,731
| -64% | -$269K | ﹤0.01% | 1255 |
|
|
2018
Q3 | $788K | Buy |
8,950
+4,250
| +90% | +$374K | 0.01% | 992 |
|
|
2018
Q2 | $489K | Hold |
4,700
| – | – | 0.01% | 1136 |
|
|
2018
Q1 | $376K | Hold |
4,700
| – | – | ﹤0.01% | 1156 |
|
|
2017
Q4 | $639K | Buy |
4,700
+1,250
| +36% | +$170K | 0.01% | 1012 |
|
|
2017
Q3 | $559K | Buy |
3,450
+1,250
| +57% | +$203K | 0.01% | 1060 |
|
|
2017
Q2 | $330K | Buy |
2,200
+200
| +10% | +$30K | ﹤0.01% | 1190 |
|
|
2017
Q1 | $312K | Sell |
2,000
-2,000
| -50% | -$312K | ﹤0.01% | 1202 |
|
|
2016
Q4 | $832K | Hold |
4,000
| – | – | 0.01% | 889 |
|
|
2016
Q3 | $916K | Hold |
4,000
| – | – | 0.01% | 835 |
|
|
2016
Q2 | $825K | Buy |
+4,000
| New | +$825K | 0.01% | 853 |
|